Development and Initial Validation of the ONCOREUM Score to Differentiate Childhood Cancer with Arthropathy from Juvenile Idiopathic Arthritis - 15/03/23
, Francesca Bovis, PhD 2, Marta Ponzano, MSc 2, Giovanni Alighieri, MD 3, Eleonora Prete, MD 4, Stefania Sorrentino, MD 5, Silvia Magni-Manzoni, MD 6, Luciana Vinti, MD, PhD 7, Micol Romano, MD 8, Nicola Santoro, MD 9, Giovanni Filocamo, MD, PhD 10, Tamara Belotti, MD, PhD 11, Francesca Santarelli, MD 12, Chiara Gorio, MD 13, Marco Cattalini, MD 14, Giulia Stabile, MSc 15, Valentino Conter, MD 16, Roberto Rondelli, MD 11, Andrea Pession, MD 17, ∗, Angelo Ravelli, MD 18, 19, ∗on behalf of the
ONCOREUM Study Group†
Abstract |
Objective |
To develop and validate a weighted score, the ONCOREUM score, that aids physicians in differentiation of cancer with arthropathy from juvenile idiopathic arthritis (JIA).
Study design |
Data were extracted from the ONCOREUM Study, a multicenter, cross-sectional investigation aimed at comparing children with cancer and arthropathy to children with JIA. Three statistical approaches were applied to develop the ONCOREUM score and assess the role of each variable in the diagnosis of cancer with arthropathy, including 2 approaches based on multivariable stepwise selection (models 1 and 2) and 1 approach on a Bayesian model averaging method (model 3). The β coefficients estimated in the models were used to assign score points. Considering that not missing a child with cancer is a mandatory clinical objective, discriminating performance was assessed by fixing sensitivity at 100%. Score performance was evaluated in both developmental and validation samples (representing 80% and 20% of the study population, respectively).
Results |
Patients with cancer and arthropathy (49 with solid tumors and 46 with hematologic malignancies without peripheral blasts) and 677 patients with JIA were included. The highest area under the receiver operating characteristic (ROC) curve (AUC) in the validation data set was yielded by model 1, which was selected to constitute the ONCOREUM score. The score ranged from −18 to 21.8, and the optimal cutoff obtained through ROC analysis was −6. The sensitivity, specificity, and AUC of the cutoff in the validation sample were 100%, 70%, and 0.85, respectively.
Conclusions |
The ONCOREUM score is a powerful and easily applicable tool that may facilitate early differentiation of malignancies with articular complaints from JIA.
Le texte complet de cet article est disponible en PDF.Keywords : bone pain, cancer, child, adolescent, juvenile idiopathic arthritis, musculoskeletal symptoms
Abbreviations : AUC, BMA, JIA, LDH, ROC, TRIPOD
Plan
| The authors declare no conflicts of interest. |
Vol 253
P. 219 - février 2023 Retour au numéro
Article précédent
- The December Effect in Pediatric Elective Surgery Utilization: Differences Between Privately and Publicly Insured Children
- Lindsay A. Gil, Daryl McLeod, Prasanth Pattisapu, Peter C. Minneci, Jennifer N. Cooper
- The Pull-to-Sit Task: Examining Infant Postural Development in Autism Spectrum Disorder
- Jessica Bradshaw, Dexin Shi, Alexis Federico, Cheryl Klaiman, Celine Saulnier
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?